Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS): protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial. [electronic resource]
Producer: 20181115Description: e020316 p. digitalISSN:- 2044-6055
- Adrenergic alpha-2 Receptor Agonists -- therapeutic use
- Anesthesia, Cardiac Procedures -- adverse effects
- Cardiac Surgical Procedures -- adverse effects
- Cardiopulmonary Bypass -- adverse effects
- Delirium -- etiology
- Dexmedetomidine -- therapeutic use
- Double-Blind Method
- Humans
- Intensive Care Units
- Sleep -- drug effects
- Sleep Wake Disorders -- etiology
- Systemic Inflammatory Response Syndrome -- complications
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.